WebMD.com to Interview HIV-VAC, Inc.'s Dr. Gordon Skinner Developer of AIDS Vaccine Business Wire
click here to return to Business Wire main menu
DonateNow





WebMD.com to Interview HIV-VAC, Inc.'s Dr. Gordon Skinner Developer of AIDS Vaccine

Business Wire - Monday, January 3, 2000

TORONTO--(BUSINESS WIRE)--Jan. 3, 2000--HIV-VAC, Inc., (OTC BB:HIVC) announces that Dr. Gordon Skinner, MD (Hons), DSc, FRCOG, FRCPath, developer of the Skinner HIV-VAC AIDS vaccine will be featured in a one-hour, live, on-line audiocast on WebMD.com on Tuesday, January 4, 2000 at 3:00 PM EST. Go to http://my.webmd.com/bigboard, then click on: AUDIOCAST: The Search for an AIDS Vaccine With Gordon Skinner WebMD's AIDS Hour is a "WebMD Live!" event that will feature Dr. Skinner discussing the Skinner HIV-VAC AIDS vaccine, which is based on a unique approach to neutralizing the AIDS virus in its many mutant forms. This method of vaccine preparation is based on a unique intracellular vaccine technology proven in clinical trials with herpes genitalis and pre-clinical research into cytomegalovirus and equine herpes vaccines. This has been under development by his team for the past 10 years at the University of Birmingham, United Kingdom.

Pre-clinical testing of the Skinner HIV-VAC AIDS vaccine is nearing completion, with Phase I & II testing underway in Russia at the Russia AIDS Centre. The Russian phase of the vaccine development program will be headed up by Dr. Vadim Pokrovsky at the Russia AIDS Centre, which has particular expertise in immunology, epidemiology and evaluation of efficacy and safety testing of vaccines.

WebMD has over eight million visitors per month and over 540,000 registered users. They are the exclusive health channel for Lycos (NASDAQ:LCOS), Excite (ATHM), and WebTV and the Microsoft Network (NASDAQ:MSFT). These events are promoted on CNN Interactive (NYSE:TWX), and with partnerships with Yahoo! Broadcast (NASDAQ:YHOO), Westwood One (NYSE:WON), the Readers Digest Association (NYSE:RDA) and the News Corporation (NYSE:NWS).

The United Nations estimates that there are currently 33 million people infected worldwide with the AIDS virus. The disease is spreading at a rate of 10,000 people each day. It is estimated that the number of people infected with the AIDS virus by the end of the year 2000 will be 55 million. Sales of anti-HIV drugs increased to more than $3 billion last year and could reach $6 billion in coming years.

The statements contained in this release which are not historical facts contain forward-looking information with respect to plans, projections or future performance of the company; the occurrence of which involves certain risks and uncertainties that could cause the company's actual results to differ materially from expected results. Such risks include the timing of implementation and the scope and success of the program described here.

CONTACT: HIV-VAC, Inc. Phil Flynn, 800/392-7961 http://www.stockprofiles.com/hivc http://www.stockhouse.com/snapshots/hivc Company Web Site: http://www.hivvac.com


000103
BW000101

Copyright © 2000 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .